Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome
Authors:
- 7 April 2018
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Abstract
Fetuses exposed to warfarin during pregnancy are at an increased risk of developing an embryopathy known as fetal warfarin syndrome or warfarin embryopathy. The most consistent anomalies are nasal hypoplasia and stippling of vertebrae or bony epiphyses. Management of pregnant patients on anticoagulation is challenging. Current guidelines suggest the use of warfarin if the therapeutic dose is ≤5 mg/day. We report the case of a newborn with signs of warfarin embryopathy born from a mother anticoagulated with warfarin due to mechanical mitral and aortic heart valves. Warfarin was required at the dose of 5 mg/day and was withheld without medical advice between weeks 8 and 10 with no other anticoagulation. The newborn presented with skeletal abnormalities and a ventricular septal defect that have not required specific treatment during the first year of life. Low-dose warfarin is associated with a lower risk of warfarin-related fetopathy but the risk of embryopathy seems unchanged.Keywords
This publication has 20 references indexed in Scilit:
- Anticoagulant choices in pregnant women with mechanical heart valves: Balancing maternal and fetal risks – the difference the dose makesThrombosis Research, 2013
- An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South AfricaCardioVascular Journal of Africa, 2012
- ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)European Heart Journal, 2011
- The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valvesObstetric Medicine, 2011
- Warfarin embryopathy: fetal manifestationsVirchows Archiv, 2010
- Optic Nerve Dysfunction in a Child Following Low-Dose Maternal Warfarin ExposureOphthalmic Genetics, 2007
- Risk of warfarin during pregnancy with mechanical valve prosthesesObstetrics & Gynecology, 2002
- Anticoagulation of Pregnant Women With Mechanical Heart ValvesArchives of internal medicine (1960), 2000
- A cluster of sulfatase genes on Xp22.3: Mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathyCell, 1995
- Maternal and fetal sequelae of anticoagulation during pregnancyThe American Journal of Medicine, 1980